HS-10582
/ Jiangsu Hansoh Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
August 21, 2026
A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HS-10582 in Healthy Subjects and Subjects With Mildly Elevated LDL-C Levels
(clinicaltrials.gov)
- P1 | N=76 | Not yet recruiting | Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd.
New P1 trial • Dyslipidemia • Metabolic Disorders
1 to 1
Of
1
Go to page
1